(CDI) Christian Dior SE - Ratings and Ratios
Fashion, Leather Goods, Wine, Spirits, Perfume, Cosmetics
Dividends
| Dividend Yield | 2.26% |
| Yield on Cost 5y | 3.36% |
| Yield CAGR 5y | 29.66% |
| Payout Consistency | 94.3% |
| Payout Ratio | 51.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.8% |
| Value at Risk 5%th | 43.4% |
| Relative Tail Risk | -8.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.26 |
| Alpha | 0.14 |
| CAGR/Max DD | -0.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.370 |
| Beta | 0.272 |
| Beta Downside | 0.348 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.27% |
| Mean DD | 22.27% |
| Median DD | 22.23% |
Description: CDI Christian Dior SE December 02, 2025
Christian Dior SE (CDI) is a French luxury conglomerate that designs, manufactures, distributes, and retails a broad portfolio of high-end products, including fashion and leather goods (e.g., Louis Vuitton, Fendi, Celine), wines and spirits (e.g., Hennessy, Moët & Chandon), perfumes and cosmetics (e.g., Dior, Guerlain, Fenty), and watches and jewelry (e.g., Tiffany, Bulgari). The group also operates retail concepts such as DFS Galleria, Sephora, and Le Bon Marché, and holds ancillary businesses in publishing, yacht building, hospitality, and real estate.
Key recent metrics: FY 2023 revenue reached €94.5 billion, up 9 % YoY, driven primarily by a 15 % surge in Asian luxury demand; operating margin stabilized at 23 % despite higher raw-material costs. The luxury sector is currently benefitting from a rebound in discretionary spending as inflation eases in major markets, while e-commerce now accounts for roughly 20 % of total sales, a share that has been accelerating post-pandemic.
For a deeper quantitative dive, the ValueRay platform offers a concise dashboard of CDI’s valuation metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (10.37b TTM) > 0 and > 6% of Revenue (6% = 10.10b TTM) |
| FCFTA 0.19 (>2.0%) and ΔFCFTA 8.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.68% (prev 7.81%; Δ 0.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.28 (>3.0%) and CFO 38.45b > Net Income 10.37b (YES >=105%, WARN >=100%) |
| Net Debt (30.89b) to EBITDA (48.25b) ratio: 0.64 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.48 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (180.4m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 67.30% (prev 68.65%; Δ -1.35pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 122.4% (prev 73.80%; Δ 48.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.67 (EBITDA TTM 48.25b / Interest Expense TTM 2.35b) >= 6 (WARN >= 3) |
Altman Z'' 3.79
| (A) 0.11 = (Total Current Assets 45.07b - Total Current Liabilities 30.45b) / Total Assets 138.72b |
| (B) 0.17 = Retained Earnings (Balance) 22.98b / Total Assets 138.72b |
| (C) 0.28 = EBIT TTM 39.10b / Avg Total Assets 137.62b |
| (D) 0.62 = Book Value of Equity 45.89b / Total Liabilities 74.30b |
| Total Rating: 3.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.87
| 1. Piotroski 7.0pt |
| 2. FCF Yield 19.10% |
| 3. FCF Margin 15.93% |
| 4. Debt/Equity 1.66 |
| 5. Debt/Ebitda 0.64 |
| 6. ROIC - WACC (= 53.30)% |
| 7. RoE 44.87% |
| 8. Rev. Trend 61.26% |
| 9. EPS Trend -3.05% |
What is the price of CDI shares?
Over the past week, the price has changed by +3.54%, over one month by +5.45%, over three months by +22.80% and over the past year by +8.13%.
Is CDI a buy, sell or hold?
What are the forecasts/targets for the CDI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 396 | -34% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 614.2 | 2.4% |
CDI Fundamental Data Overview November 27, 2025
Market Cap EUR = 104.46b (104.46b EUR * 1.0 EUR.EUR)
P/E Trailing = 22.9125
P/S = 1.2613
P/B = 4.4332
Beta = 1.026
Revenue TTM = 168.41b EUR
EBIT TTM = 39.10b EUR
EBITDA TTM = 48.25b EUR
Long Term Debt = 12.45b EUR (from longTermDebt, last quarter)
Short Term Debt = 12.60b EUR (from shortTermDebt, last quarter)
Debt = 39.18b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 30.89b EUR (from netDebt column, last quarter)
Enterprise Value = 140.49b EUR (104.46b + Debt 39.18b - CCE 3.15b)
Interest Coverage Ratio = 16.67 (Ebit TTM 39.10b / Interest Expense TTM 2.35b)
FCF Yield = 19.10% (FCF TTM 26.83b / Enterprise Value 140.49b)
FCF Margin = 15.93% (FCF TTM 26.83b / Revenue TTM 168.41b)
Net Margin = 6.16% (Net Income TTM 10.37b / Revenue TTM 168.41b)
Gross Margin = 67.30% ((Revenue TTM 168.41b - Cost of Revenue TTM 55.07b) / Revenue TTM)
Gross Margin QoQ = 66.84% (prev 65.27%)
Tobins Q-Ratio = 1.01 (Enterprise Value 140.49b / Total Assets 138.72b)
Interest Expense / Debt = 1.51% (Interest Expense 590.0m / Debt 39.18b)
Taxrate = 31.31% (2.68b / 8.57b)
NOPAT = 26.86b (EBIT 39.10b * (1 - 31.31%))
Current Ratio = 1.48 (Total Current Assets 45.07b / Total Current Liabilities 30.45b)
Debt / Equity = 1.66 (Debt 39.18b / totalStockholderEquity, last quarter 23.58b)
Debt / EBITDA = 0.64 (Net Debt 30.89b / EBITDA 48.25b)
Debt / FCF = 1.15 (Net Debt 30.89b / FCF TTM 26.83b)
Total Stockholder Equity = 23.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.48% (Net Income 10.37b / Total Assets 138.72b)
RoE = 44.87% (Net Income TTM 10.37b / Total Stockholder Equity 23.11b)
RoCE = 109.9% (EBIT 39.10b / Capital Employed (Equity 23.11b + L.T.Debt 12.45b))
RoIC = 58.69% (NOPAT 26.86b / Invested Capital 45.76b)
WACC = 5.39% (E(104.46b)/V(143.63b) * Re(7.02%) + D(39.18b)/V(143.63b) * Rd(1.51%) * (1-Tc(0.31)))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.98% ; FCFE base≈21.78b ; Y1≈21.33b ; Y5≈21.71b
Fair Price DCF = 2137 (DCF Value 385.59b / Shares Outstanding 180.4m; 5y FCF grow -3.04% → 3.0% )
EPS Correlation: -3.05 | EPS CAGR: -45.76% | SUE: 0.0 | # QB: 0
Revenue Correlation: 61.26 | Revenue CAGR: 14.88% | SUE: N/A | # QB: 0